Jaguar Health (JAGX) EBITDA Margin (QoQ) (2015 - 2026)
Jaguar Health (JAGX) EBITDA Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,810.93 Bn | 1,810.87 Bn | - |
| 2 | Akari Therapeutics | 997.56 Bn | 997.56 Bn | - |
| 3 | BeOne Medicines | 475.29 Bn | 470.50 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.40 Bn | 117.15 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.15 Bn | 63.40 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.26 Bn | 49.08 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.21 Bn | 35.20 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - |
| 10 | Jaguar Health | 513,982.75 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,686.00 |
| Dec 31, 2025 | -42,186.00 |
| Sep 30, 2025 | 3,401.00 |
| Jun 30, 2025 | 15,674.00 |
| Mar 31, 2025 | -19,306.00 |
| Dec 31, 2024 | 120.00 |
| Sep 30, 2024 | 3,084.00 |
| Jun 30, 2024 | 8,493.00 |
| Mar 31, 2024 | -2,086.00 |
| Dec 31, 2023 | -1,619.00 |
| Sep 30, 2023 | -396.00 |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | -223,403.00 |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | -9,406.00 |
| Jun 30, 2022 | 5.85 Mn |
| Mar 31, 2022 | -5.82 Mn |
| Dec 31, 2021 | 102,914.00 |
| Sep 30, 2021 | 150,598.00 |
| Jun 30, 2021 | -232,975.00 |